Skip to main content
Clinical Trials/NCT01640158
NCT01640158CompletedNot Applicable

BRAVE Trial: Broad-spectrum Cognitive Remediation Available to Veterans: Effects of a Brain Plasticity-based Program in Mild Traumatic Brain Injury (mTBI)

Posit Science Corporation1 site in 1 country86 target enrollmentStarted: September 1, 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
86
Locations
1
Primary Endpoint
Change in Functional Performance

Study Overview

Brief Summary

The primary objective of this study is to evaluate the effects of plasticity-based, adaptive cognitive remediation on the cognitive abilities, functional status and quality of life of soldiers and veterans diagnosed with persistent post-concussive symptoms (PPCS) following a mild traumatic brain injury (mTBI, also referred to as a concussion, or blast exposure), as compared to a computer-based control.

Detailed Description

This study is a multi-site, prospective, parallel arm, double-blind, randomized, controlled clinical trial to assess the safety and efficacy of plasticity-based, adaptive, computerized cognitive remediation treatment versus a computer-based control. Both the study and the cognitive remediation treatments meet the criteria of Non-Significant Risk.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Subjects must be 18 - 50 years of age at the time of consent
  • •Subjects must have a diagnosis of mTBI
  • •Subjects must have persistent cognitive dysfunction confirmed by an objective measure (as recommended by the ICD-10 definition for post-concussion syndrome) or a subjective measure (as recommended by the DSV-IV definition of post-concussional disorder).
  • •Subjects must be at least three months out from their most recent TBI, concussion, and/or blast exposure to minimize the effects of spontaneous recovery, as verified through participant interview.
  • •Subjects must be fluent English speakers.
  • •Subjects must have adequate sensorimotor capacity to perform the program in the judgment of the consenting clinician.

Exclusion Criteria

  • •Subjects must not have a history of penetrating head wounds or a diagnosis of moderate or severe TBI.
  • •Subjects must not be in-patients.
  • •Subjects must not have a diagnosis of an illness or condition with known cognitive consequences (e.g., schizophrenia, bipolar disorder, cancer, multiple sclerosis).
  • •Subjects must not show suicidal ideation as measured by the Columbia-Suicide Severity Rating Scale (C-SSRS).
  • •Subjects must now show signs of intoxication due to current substance abuse (including alcohol and/or illegal drugs) during any in person visit.
  • •Subjects must not have clinically significant visual field deficits noted by the consenting staff member by direct observation or by medical history.
  • •Subjects must not be judged to be lacking effort.
  • •Subjects must not have problems performing assessments or comprehending or following spoken instructions.
  • •Subjects must not be enrolled in a concurrent clinical trial involving an investigational pharmaceutical, nutraceutical, medical device, or behavioral treatment for TBI that could affect the outcome of this study.

Arms & Interventions

Experimental Treatment

Experimental

Computerized plasticity-based adaptive cognitive training, up to 65 hours

Intervention: Computerized Plasticity-based Adaptive Cognitive Training (Other)

Active Comparator

Active Comparator

Commercially available computerized training, up to 65 hours

Intervention: Commercially available computerized training (Other)

Outcomes

Primary Outcomes

Change in Functional Performance

Time Frame: After three months of training

Between-group magnitude of change in sum time of all tasks in the Timed Instrumental Activities of Daily Living (TIADL). Higher scores indicate greater impairment in functional performance.

Change in Cognitive Function

Time Frame: After three months of training

Between-group magnitude of change in composite score with the measure constructed from Rey Auditory Verbal Learning Test (RAVLT) sum of trials 1-5 (immediate verbal memory), RAVLT delayed verbal recall, the Ruff Light Trails Test (RULIT) sum of trials 2-10 (immediate visual memory), RULIT delayed recall scores, digit span (WAIS, sum of forwards, backwards, sequencing), symbol span (WMS), anti-saccades, flanker, and set-shifting (each from the EXAMINER battery).

Secondary Outcomes

  • Change in Short-Term Visual Memory Span(After three months of training and 3 months after training completion)
  • Change in Cognitive Symptoms(After three months of training and 3 months after training completion)
  • Change in Physical Health-Related Quality of Life(After three months of training and 3 months after training completion)
  • Change in Neurobehavioral Symptoms(After three months of training and 3 months after training completion)
  • Change in PTSD Symptoms(After three months of training and 3 months after training completion)
  • Change in Executive Function Symptoms(After three months of training and 3 months after training completion)
  • Change in Immediate Verbal Memory(After three months of training and 3 months after training completion)
  • Change in Depressive Symptoms(After three months of training and 3 months after training completion)
  • Change in TBI Functional Status(After three months of training and 3 months after training completion)
  • Change in Delayed Verbal Memory(After three months of training and 3 months after training completion)
  • Change in Immediate Visual Memory(After three months of training and 3 months after training completion)
  • Change in Short-Term Verbal Memory Span(After three months of training and 3 months after training completion)
  • Change in Response Inhibition(After three months of training and 3 months after training completion)
  • Change in Mental Health-Related Quality of Life(After three months of training and 3 months after training completion)
  • Change in Delayed Visual Memory(After three months of training and 3 months after training completion)
  • Change in Cognitive Flexibility(After three months of training and 3 months after training completion)
  • Change in Functional Performance(3 months after training completion)
  • Change in Inhibition of Reflexive Saccade(After three months of training and 3 months after training completion)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials